To investigate whether loss of GLS2 expression promotes tumorigenesis in HCC, endogenous GLS2 in PLC/PRF/5 cells was knocked down by stable transduction of shRNA vectors against GLS2 (Figure 3A). The gene discussed is GLS2; the disease is hepatocellular carcinoma.